XYNOMIC PHARMACEUTICALS HOLDINGS, INC.

Xynomic Pharmaceuticals Holdings, Inc. (ticker: XYN) is a biopharmaceutical company focused on the development and commercialization of oncology therapeutics, operating primarily in China and across global markets. The company filed its quarterly report on Form 10-Q with the SEC on November 13, 2018, reflecting its status as a publicly traded entity following its 2018 business combination that brought it to market. Active in the pharmaceutical and life sciences sector, Xynomic has pursued a strategy of in-licensing and advancing cancer treatment candidates through clinical development. To access the full filing history, deal timeline, and data metrics for XYN and hundreds of other SPAC-related companies, sign up for a SpacDesk account at spacdesk.com.